Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kazuhisa Ohgaki"'
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 68:369-373
Autor:
Kazuhisa Ohgaki, Toshihiro Nagai, Satoshi Nagayama, Hirohiko Yamabe, Hisanori Matsushiro, Taisuke Hori
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 32:2010-2014
Autor:
Kohei Satoh, Seiji Yamasaki, Takehisa Harada, Kazuhisa Ohgaki, Keiichi Mise, Norimichi Kan, Takayoshi Tobe, Yoshio Moriguchi, Hiroshi Kodama, You Ichinose
Publikováno v:
Biotherapy. 6:63-71
In patients with Stage II or III breast cancer and in patients with liver metastases from breast cancer, we examined cellular interaction in the cytotoxicity against autologous tumor cells by interleukin-2(IL-2)-cultured lymphocytes (CL) and fresh pe
Autor:
Takashi Okino, Kohei Satoh, Taisuke Hori, Norimichi Kan, Seiji Yamasaki, Kazuhisa Ohgaki, Takayoshi Tobe, Keiichi Mise, Takehisa Harada
Publikováno v:
Biotherapy. 6:41-49
Twenty-four patients with liver metastases from gastric or colorectal cancer were treated with OK-432-combined adoptive immunotherapy (AIT). Lymphocytes isolated from regional lymph nodes or peripheral blood were cultured with medium containing T cel
Autor:
Seiji Yamasaki, Yasufumi Teramura, Kohei Satoh, Hiroshi Kodama, Norimichi Kan, Kazuhisa Ohgaki, Takashi Okino, Taisuke Hori, Takehisa Harada, Takayoshi Tobe, Keiichi Mise
Publikováno v:
Biotherapy. 5:21-29
We developed a local AIT using PEL cultured with TCGF combined with preadministration of OK-432. Twenty-six patients of breast cancer with pleural effusion have been treated with this therapy since 1983. PEL expanded and tumor cells collapsed by day
Autor:
Taisuke Hori, Kohei Satoh, Takashi Okino, Norimichi Kan, Takehisa Harada, Hiroshi Kodama, Kazuhisa Ohgaki, Yasufumi Teramura, Seiji Yamasaki, Takayoshi Tobe, Keiichi Mise
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 118:157-162
The response and survival of 26 patients with liver metastases from breast cancer, who received OK-432-combined adoptive immunotherapy from 1984 to 1990, were evaluated. OK-432-combined adoptive immunotherapy was comprised sequential treatment via th
Autor:
Seiji Yamasaki, Kohei Satoh, Takayoshi Tobe, Masaki Nakanishi, Kazuhisa Ohgaki, Takashi Okino, Yasufumi Teramura, Keiichi Mise, Norimichi Kan
Publikováno v:
Cancer Immunology Immunotherapy. 32:273-279
A murine plasmacytoma MOPC 104E (MOPC) is highly sensitive to chemotherapeutic agents such as cyclophosphamide and mitomycin C as well as to immunotherapy (OK-432-combined adoptive immunotherapy using interleukin-2-cultured killer cells). In the pres
Autor:
Souhei Minematsu, Shiraishi T, Takayoshi Tobe, Tadao Manabe, Tomoharu Sugie, Norimichi Kan, Koutarou Uchida, Kazuhisa Ohgaki, Hirohiko Yamabe, Kiyoyuki Takahashi
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 24:930-934
症例は46歳白人男性, 下腹部痛を主訴として来院.血清CEA異常高値 (124ng/ml) 小腸造影, 選択的血管造影により小腸癌の術前診断で開腹した.回腸末端60cm口側, 腸間膜対側に直径約2cmの腫瘍, な
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 35(4)
A 60-year-old woman was admitted to the hospital with left thigh pain. She had undergone mastectomy and axillary lymph node dissection for right breast cancer (T3N2M0) five years and two months earlier. The pathological diagnosis then was invasive du
Publikováno v:
Biotherapy. 2:213-222
A streptococcal preparation, OK-432, was orally administered at a dose of 5 KE to patients with gastric or colorectal cancer for 7-14 days before their operations, and its immunomodulatory effects on peripheral blood lymphocytes (PBL), regional node